References
- Palmiter R D, Brinster RL. Germ-line transformation of mice. Annu Rev Genet 1986; 20: 465–499
- Lieman-Hurwitz J, Dafni N, Lavie V, Groner Y. Human cytoplasmic superoxide dismutase cDNA clone: A probe for study in the molecular biology of Down syndrome. Proc Natl Acad Sci USA 1982; 79: 2808–2811
- Levanon D, Lieman-Hurwitz J, Dafhi N, Wigderson M, Sherman L, Bernstein Y, Laver-Rudich Z, Danciger E, Stein O, Groner Y. Architecture and anatomy of the chromsomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J 1985; 4: 77–84
- Elroy-Stein O, Bernstein Y, Groner Y. Overproduction of human Cu/Zn-superoxide dismutase in transfected cells: Extenuation of paraquat-mediated cytotoxicity and enhancement of lipid peroxidation. EMBO J 1986; 5: 515–622
- Epstein C J, Avraham K B, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: Animal model of dosage effects in Down syndrome. Proc Natl Acad Sd USA 1987; 84: 8044–8048
- Gordon J W, Ruddle FH. Gene transfer into mouse embryos: Production of transgenic mice by pronuclear injection. Methods Enzymol 1983; 101: 411–433
- Groner Y, Elroy-Stein O, Avraham K B, Yarom R, Schickler M, Knobler H, Rotman G. Down syndrome clinical symptoms are manifested in transfected cells and transgenic mice overexpressing the human Cu/Zn-superoxide dismutase gene. J Physiol (Paris) 1990; 84: 53–77
- Minc-Golomb D, Knobler H, Groner Y. Gene dosage of CuZnS-SOD and Down's syndrome: Dimished prostaglandin synthesis in human trisomy 21, transfected cells and transgenic mice. EMBO J 1991; 10: 2119–2124
- White C W, Avraham K B, Shanley P F, Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 1991; 87: 2162–2168
- Paller M S, Hoidal J R, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 1984; 74: 1156–1164
- Gamelin L M, Zager RA. Evidence against oxidant injury as a critical mediator of postischemic acute renal failure. Am J Physiol 1988; 255: F450–F460
- Shanley P F, White C W, Avraham K, Groner Y, Burke TJ. Renal ischemia-reperfusion in transgenic mice with endogenous high levels of superoxide dismutase (SOD). J Am Soc Nephrol 1990; 1: 604A